Boala Alzheimer și alte forme de demență.
73 de articolePreliminary research presented at the European Academy of Neurology Congress 2026 shows that exposure to extreme temperatures is associated with increased emergency department visits among people with dementia. This highlights environmental vulnerability as an important health and safety consideration for dementia patients.
Research identifies Arc, a native brain protein, as a mediator of toxic tau spread between neurons via extracellular vesicles in Alzheimer's disease. While Arc enables sick neurons to survive longer by expelling tau aggregates, it also paradoxically promotes pathology transmission to healthy cells, suggesting the extracellular space as a potential therapeutic intervention point.
This review examines the relationship between loneliness and social isolation as major risk factors for Alzheimer's disease and cognitive decline, with particular attention to sex differences. The authors discuss mechanisms linking isolation to AD pathology and propose approaches for developing prevention and treatment strategies based on understanding these associations.
Researchers developed a tablet-based software application designed to slow cognitive and communicative decline in individuals with Alzheimer's disease for home use. A randomized controlled trial with 32 participants (mild, moderate, and severe stages) compared outcomes between those using the application plus pharmacological treatment versus pharmacological treatment alone.
This health economics study examines costs associated with using neuroimaging (PET and MRI) to identify Alzheimer's disease patients most likely to benefit from lecanemab treatment over three years. The authors highlight a critical concern: approximately 78% of patients with mild cognitive impairment do not progress to dementia, making prophylactic treatment in all MCI patients costly and ethically problematic; they identify combined fluorodeoxyglucose and MRI imaging as the most cost-efficient approach at $177,000 per positive outcome with adjusted lecanemab pricing.
Disease-modifying Alzheimer's drugs provide hope for some patients, though their efficacy varies. The article emphasizes that dementia care must extend beyond pharmacological interventions to preserve quality of life and human dignity for all affected individuals, regardless of medication response.
Alzheimer's disease is characterized by the accumulation of tau, a toxic protein that damages neurons. As tau spreads throughout the brain to new regions, cognitive decline accelerates and the disease progresses in severity.
This study examined whether plasma levels of ergothioneine and its metabolite hercynine correlate with resistance to cognitive decline in older dementia-free individuals with Alzheimer's amyloid pathology. Higher ergothioneine metabolism (HC:ET ratio) attenuated the relationship between amyloid biomarkers and cognitive decline, suggesting ergothioneine's potential neuroprotective role warrants further investigation.
This systematic review of five studies involving over 1.6 million participants examines how microvascular complications from diabetes—particularly neuropathy and nephropathy—increase dementia risk, with hazard ratios ranging from 1.12-1.26. Poor glycemic control (HbA1c) and its variability independently contribute to cognitive decline, with each 1% increase in HbA1c associated with an 8% increased dementia risk.
This study investigates potential mechanisms linking thyroid dysfunction (hyper- and hypothyroidism) to Alzheimer's disease risk by measuring serum biomarkers including Aβ42, BDNF, acetylcholinesterase, and calcium in older adults. Results showed elevated Aβ42 and BDNF levels in both thyroid disorder groups compared to controls, with more pronounced elevations in hypothyroid patients, suggesting thyroid dysfunction may influence cognitive decline pathways.
Researchers identified 14 blood metabolites associated with cognitive function and 22 linked to brain structure changes in cognitively normal middle-aged adults, with lifestyle and gut microbiota playing significant roles in shaping these metabolite profiles. Ergothioneine emerged as a promising metabolite marker connected to cognition, potentially offering early identification targets for dementia prevention.
Researchers identified a previously unknown type of programmed cell death called karyoptosis, characterized by nuclear disintegration and driven by interaction between p38 MAP kinase and LaminB1 proteins. This mechanism was observed in approximately 35% of neurons in the frontal cortex of Alzheimer's disease patients, potentially offering new insights into neuronal loss in the disease.
Iron accumulation in the brain is being investigated as a contributing factor to neurodegenerative diseases, particularly Alzheimer's and Parkinson's disease. Scientists are studying this mechanism as part of ongoing efforts to understand the complex processes underlying these conditions affecting millions worldwide.
A study in Nature Aging identified that age-related reduction of a specific brain protein may contribute to neuronal dysfunction in Alzheimer's disease. The research examines protein-mediated mechanisms in the brain's clearance system relevant to memory loss and cognitive decline.
Research indicates that average daytime light exposure above 1,000 lux is associated with a 16% reduction in dementia risk. Getting less than 42 minutes of bright daily light exposure was found to be a stronger predictor of dementia than six conventional clinical risk factors.
CADASIL is a hereditary condition affecting small blood vessels in the brain, causing recurrent strokes and progressive cognitive decline leading to early-onset dementia. Researchers are using zebrafish as a model organism to better understand the disease mechanisms and develop potential treatments.
The article examines how praise from caregivers can influence task completion and emotional well-being in dementia patients, noting that while encouragement is beneficial, inappropriate or condescending praise may be counterproductive. It highlights the importance of individualized, context-appropriate communication strategies in dementia care settings.
A Rice University study investigates how personality traits influence the physical and emotional health outcomes of spouses caring for dementia patients. The research suggests that individual differences in personality may explain why chronic caregiving stress affects different caregivers' health in varying ways.
